Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 4Leukemia 4Lymphoma, Non-Hodgkin 3Congenital Abnormalities 3Waldenstrom Macroglobulinemia 2Recurrence 2Myeloproliferative Disorders 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Tongue Neoplasms 1Thyroid Neoplasms 1Thymus Neoplasms 1Thrombocythemia, Essential 1Testicular Neoplasms 1Stomach Neoplasms 1Skin Neoplasms 1Sarcoma, Synovial 1Sarcoma, Kaposi 1Sarcoma 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1

Interventions

fludarabine phosphate 27Peripheral Blood Stem Cell Transplantation 25Cyclophosphamide 24Busulfan 17Tacrolimus 16Whole-Body Irradiation 15Mycophenolic Acid 14Methotrexate 12Cyclosporine 12Antilymphocyte Serum 10Melphalan 7Filgrastim 7Etoposide 7fludarabine 6Radiotherapy 5Decitabine 5Carboplatin 5ruxolitinib 4Topotecan 4Methylprednisolone 4Flow Cytometry 4Cytarabine 4Thiotepa 3Imatinib Mesylate 3Cytogenetic Analysis 3Alemtuzumab 3veliparib 2merphos 2liposomal amphotericin B 2aldesleukin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polycythemia Vera × Biological Therapy × Other hematologic neoplasm × Clear all
NCT00066417 2013-05-01

Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia

National Cancer Institute (NCI)

Phase 2 Terminated
51 enrolled
MyeloidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡